| 摘要 |
PROBLEM TO BE SOLVED: To provide a therapeutic agent for hepatitis, particularly a therapeutic agent for non-alcoholic steatohepatitis and a therapeutic agent for acute hepatitis.SOLUTION: The invention relates to adipose tissue-derived interstitial cell groups having an excellent inflammation inhibitory effect, fibrosis inhibitory effect, metabolic abnormality improving effect (particularly fatty acid metabolism improving effect), and hepatopathy improving effect, wherein the ratio of CD105 positive cells is 0.1-40.0% and/or the ratio of CD45 positive cells is 0.1-20.0% to all the cells; and to a therapeutic agent for a non-alcoholic steatohepatitis, a therapeutic agent for acute hepatitis, and a therapeutic agent for metabolic abnormality containing the cell groups as an active ingredient.SELECTED DRAWING: None |
